The action of Metaloproteinases in the Atherosclerotic Diseases
Main Article Content
Abstract
Cardiovascular diseases represent the main cause of morbidity and mortality in the world and are epidemic events involving the atherosclerosis and coronary artery disease in particular. There are a wide variety of factors and markers associated with the development and aggravation of these diseases, including atherosclerosis. Subclinical Atherosclerosis can be determined by serum inflammatory markers present in the atherogenic process. Such markers can take a direct or indirect indicator role on atherosclerotic cardiovascular disease. The extracellular matrix metalloproteinases are biomarkers closely related into modifying and remodeling of vascular wall and other tissues and can represent predictive value patterns to support diagnosis. This review discusses the function and types of matrix metalloproteinases and its use as an indicator of support for the diagnosis of atherosclerosis.
Downloads
Article Details
Authors who publish with this journal agree to the following terms:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY) that allows others to share and adapt the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.References
Ferraz MLF. Avaliação morfológica da aterosclerose em aortas de pacientes autopsiados. Tese (Doutorado) – Universidade Federal do Triângulo Mineiro, Uberaba, 2008.
Borges LF, Touat Z, Leclercq A, Zen AA, Jondeau G, Franc B, et al. Tissue diffusion and retention of metalloproteinases in ascending aortic aneurysms and dissections. Hum Pathol. 2009;40(3):306-13.
http://dx.doi.org/10.1016/j.humpath.2008.08.002
Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem. 1999;274(31):21491-4. http://dx.doi.org/10.1074/jbc.274.31.21491
Opdenakker G, Van den Steen PE, Van Damme J. Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001;22(10):571-9. http://dx.doi.org/10.1016/S1471-4906(01)02023-3
Galis ZS, Khatri JJ. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ Res. 2002;90(3):251-62.
Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003;92(8):827-39. http://dx.doi.org/10.1161/01.RES.0000070112.80711.3D
Klein T, Bischoff R. Physiology and pathophysiology of matrix metalloproteinases. Amino Acids. 2011;41(2):271-90. http://dx.doi.org/10.1007/s00726-010-0689-x
Sang QX. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 1998;8(3):171-7. http://dx.doi.org/10.1038/cr.1998.17
Rutschow S, Li J, Schultheiss HP, Pauschinger M. Myocardial proteinases and matrix remodeling in inflammatory heart disease. Cardiovasc Res. 2006;69(3):646-56. http://dx.doi.org/10.1016/j.cardiores.2005.12.009
Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 2000;14(17):2123-33. http://dx.doi.org/10.1101/gad.815400
Miyage SPH. Análise in vitro da expressão de proteínas da matriz extracelular (ECM) e de metaloproteinases de matriz (MMPs) em células- tronco da polpa dentária humana. Tese (Doutorado) – Universidade de São Paulo, São Paulo, 2008.
Fang C, Wen G, Zhang L, Lin L, Moore A, Wu S, Ye S, Xiao Q. An important role of matrix metalloproteinase-8 in angiogenesis in vitro and in vivo. Cardiovasc Res. 2013;99(1):146-55. http://dx.doi.org/10.1093/cvr/cvt060
Xiao Q, Zhang F, Lin L, Fang C, Wen G, Tsai TN, et al. Functional role of Matrix Metalloproteinase-8 in Stem/Progenitor cell migration and their recruitment into atherosclerotic lesions. Circ Res. 2013;112:35-47. http://dx.doi.org/10.1161/CIRCRESAHA.112.274019
Lima ES, Couto RD. Estrutura, metabolismo e funções fisiológicas da lipoproteína de alta densidade. J Bras Patol Med Lab. 2006;42(3):169-78. http://dx.doi.org/10.1590/S1676-24442006000300005
Galkina E, Ley K. Immune and inflammatory mechanisms of atherosclerosis. An Rev Immunol. 2009;27:165-97. http://dx.doi.org/10.1146/annurev.immunol.021908.132620
Siefert SA, Sarkar R. Matrix metalloproteinases in vascular physiology and disease. Vascular. 2012;20(4):210-6. http://dx.doi.org/10.1258/vasc.2011.201202
Torzewski M, Suriyaphol P, Paprotka K, Spath L, Ochsenhirt V, Schmitt A, et al. Enzymatic modification of low-density lipoprotein in the arterial wall: a new role for plasmin and matrix metalloproteinases in atherogenesis. Arterioscler Thrombos Vasc Biol. 2004;24(11):2130-6. http://dx.doi.org/10.1161/01.ATV.0000144016.85221.66
Kalela A. Factors affecting serum matrix metalloproteinase-9 with special reference to atherosclerosis. Thesis (Doctoral) – Medical School of the University of Tampere. 2002.
Libby P. Inflammation and atherosclerosis. Nature. 2002;420(6917):868-74. http://dx.doi.org/10.1038/nature01323
Inoue T, Kato T, Takayanagi K, Uchida T, Yaguchi I, Kamishirado H, et al. Circulating matrix metalloproteinase-1 and -3 in patients with and acute coronary syndrome. Am J Cardiol. 2003;92:1461-4. http://dx.doi.org/10.1016/j.amjcard.2003.08.061
Yu WH, Yu S, Meng Q, Brew K, Woessner JF Jr. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem. 2000;275(40):31226-32. http://dx.doi.org/10.1074/jbc.M000907200
Newby AC. Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev. 2005;85(1):1-31. http://dx.doi.org/10.1152/physrev.00048.2003
Fonseca ALM. Metaloproteinases de matriz e incorporação de colesterol na lipoproteína de alta densidade (HDL) na doença carotídea. Tese (Doutorado) – Fundação Oswaldo Cruz, Salvador, 2012. p. 93.
Mallat Z. Inflammation, and atherosclerotic lesion growth matrix metalloproteinase-8 and the regulation of blood pressure, vascular. Circ Res. 2009;105:827-9. http://dx.doi.org/10.1161/CIRCRESAHA.109.208595
Karapanagiotidis GT, Antonitsis P, Charokopos N, Foroulis CN, Anastasiadis K, Rouska E, et al. Serum levels of matrix metalloproteinases -1,-2,-3 and -9 in thoracic aortic diseases and acute myocardial ischemia. J Cardiothoracic Surg. 2009;4:59. http://dx.doi.org/10.1186/1749-8090-4-59
Jackson ZS, Dajnowiec D, Gotlieb AI, Langille BL. Partial off-loading of longitudinal tension induces arterial tortuosity. Arterioscler Thrombos Vasc Biol. 2005;25(5):957-62. http://dx.doi.org/10.1161/01.ATV.0000161277.46464.11
Sebastian L, Mach F, Montecucco F. Role of Matrix Metalloproteinase-8 in Atherosclerosis. Mediat Inflamm. 2013;(2013):1-6. http://dx.doi.org/10.1155/2013/659282
Beaudeux JL, Giral P, Bruckert E, Foglietti MJ, Chapman MJ. Métalloprotéases matricielles et athérosclérose. Perspectives thérapeutiques. Ann Biol Clin. 2003;61(2):147-58.
Halpert I, Sires UI, Roby JD, Potter-Perigo S, Wight TN, Shapiro SD, et al. Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme. Proc Natl Acad Sci U S A. 1996;93(18):9748-53. http://dx.doi.org/10.1073/pnas.93.18.9748
Djurić T, Zivković M, Stanković A, Kolaković A, Jekić D, Selaković V, Alavantić D. Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis. J Clin Lab Anal. 2010;24(4):246-51. http://dx.doi.org/10.1002/jcla.20393
Wang KF, Huang PH, Chiang CH, Hsu CY, Leu HB, Chen JW, Lin SJ. Usefulness of plasma matrix metalloproteinase-9 level in predicting future coronary revascularization in patients after acute myocardial infarction. Coron Artery Dis. 2013;24(1):23-8. http://dx.doi.org/10.1097/MCA.0b013e32835aab4a
Lubos E, Schnabel R, Rupprecht HJ, Bickel C, Messow CM, Prigge S, et al. Prognostic value of tissue inhibitor of metalloproteinase-1 for cardiovascular death among patients with cardiovascular disease: results from the AtheroGene Study. Eur Heart J. 2006;27(2):150-6. http://dx.doi.org/10.1093/eurheartj/ehi582
Romero JR, Vasan RS, Beiser AS, Polak JF, Benjamin EJ, Wolf PA, et al. Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study. J Stroke Cerebrovasc Dis. 2008;17(6):412-7. http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2008.06.002
Schwartz SM, Galis ZS, Rosenfeld ME, Falk E. Plaque rupture in humans and mice. Arterioscler Thrombos Vasc Biol. 2007;27:705-13. http://dx.doi.org/10.1161/01.ATV.0000261709.34878.20
Xin JIG, He-Song ZG, Yi G, Zhi-Bin Z, Bing-Shan TG, Fu-Kang LI. The expression of matrix metalloproteinases-9, transforming growth factor-β1 and transforming growth factor- receptor in human atherosclerotic plaque and their relationship with plaque stability. Chin Med J. 2004;117(12):1825-9.
Wilson D, Massaeli H, Russell JC, Pierce GN, Zahradka P. Low matrix metalloproteinase levels precede vascular lesion formation in the JCR:LA-cp rat. Mol Cell Biochem. 2003;249(1-2):151-5. http://dx.doi.org/10.1023/A:1024747008288
Gaubatz JW, Ballantyne CM, Wasserman BA, Max HE, Chambless LE, Boerwinkle E, Hoogeveen RC. Association of circulating matrix metalloproteinases with carotid artery characteristics: the atherosclerosis risk in Communities Carotid MRI Study. Arterioscler Thrombos Vasc Biol. 2010;30(5):1034-42. http://dx.doi.org/10.1161/ATVBAHA.109.195370
Motterle A, Xiao Q, Kiechl S, Pender SL, Morris GE, Willeit J, Caulfield MJ, Ye S. Influence of matrix metalloproteinase-12 on fibrinogen level. Atherosclerosis. 2012;220(2):351-4. http://dx.doi.org/10.1016/j.atherosclerosis.2011.11.003
Libby, P. Collagenases and cracks in the plaque. J Clin Invest. 2013;123(8):3201-3. http://dx.doi.org/10.1172/JCI67526
Siasos G, Tousoulis D, Kioufis S, Oikonomou E, Siasou Z, Limperi M, Papavassiliou Ag, Stefanadis C. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases. Curr Top Med Chem. 2012;12(10):1132-48. http://dx.doi.org/10.2174/1568026611208011132
Sahara M, Ikutomi M, Morita T, Minami Y, Nakajima T, Hirata Y, et al. Deletion of Angiotensin-converting Enzyme 2 Promotes the Development of Atherosclerosis and Arterial Neointima Formation. Cardiovasc Res. 2014;101(2):236-46. http://dx.doi.org/10.1093/cvr/cvt245.
Guimarães DA, Rizzi E, Ceron CS, Martins-Oliveira A, Gerlach RF, Santos JET. Inibição de metaloproteinases da matriz extracelular: uma possível estratégia terapêutica na hipertensão arterial? Rev Bras Hipertens. 2010;17(14):226-30.
Silva DC, Gerchiaro G. Relações patofisiológicas entre estresse oxidativo e arteriosclerose. Qim Nova. 2011;34(2):300-5. http://dx.doi.org/10.1590/S0100-40422011000200024
Araújo RVS, Silva FO, Melo-Júnior MR; Porto AL. Metaloproteinases: aspectos fisiopatológicos sistêmicos e sua importância na cicatrização. Rev Ciênc Méd Biol. 2011;10(1):82-8.
Silva JM, Saldanha C. Endotélio Arterial e Aterotrombogénese II: disfunção endotelial e desenvolvimento das lesões aterotrombóticas. Rev Port Cardiol. 2006;25(12)1159-86.